Allan J. Pantuck

Chair of the UCLA IRB Committee and thought leader in the field of cancer immunotherapy and co-founder of Kite Pharma. Expert in clinical trial design and involved in the keynote study showing efficacy of sunitinib (Pfizer) in patients with renal cell carcinoma.

Extensive experience on clinical trials design, performance and regulatory affairs. Allan is the executive chair of the UCLA IRB Committee, Professor of Urology at the David Geffen School of Medicine at UCLA and Vice Chair of Academic Affairs for the Department of Urology, Executive Chair of the UCLA IRB, a member of the Executive Committee of the Institute of Urologic Oncology. Allan performed his urology/oncology fellowship at UCLA School of Medicine and holds an MD degree from Robert Wood Johnson Medical School.